Skip to main content
Premium Trial:

Request an Annual Quote

ValiFinn Buys Pharmatest Services' Biomarker Business

NEW YORK (GenomeWeb News) – ValiRx today announced its wholly owned subsidiary ValiFinn has bought the biomarkers business of Pharmatest Services for €75,000 ($96,000) plus stock.

The purchase includes five patent families and patent applications and related intellectual property. Pharmatest, based in Finland, also received 15 million shares of ValiRx stock at a price of .52 pence per share.

Pharmatest also is eligible to receive royalties based on future revenues related to the purchased IP and for the life of the patents, ValiRx said.

ValiFinn plans to create a new business unit with the biomarker business, which currently provides contract research services to pharmaceutical companies. ValiFinn will leverage the business to further the development of companion biomarker diagnostics to complement ValiRx's therapeutics, IP, and companion diagnostic work.

Based in London, ValiRx is focused on developing cancer diagnostics and therapeutics using epigenomics technology. It said in a statement that pairing biomarker-based diagnostics with a targeted drug "is emerging as a key part of personalized medicine, particularly in cancer patients."

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.